<DOC>
	<DOCNO>NCT02202512</DOCNO>
	<brief_summary>Main objective investigate measure glomerular filtration rate ( mGFR ) assess iohexol clearance healthy male normovolemic subject oral administration single repeat dos BI 1060469 , BI 1021958 . The secondary objective trial investigate glomerular filtration rate ( GFR ) assess 24 hour creatinine clearance healthy male normovolemic subject oral administration single repeat dos BI 1060469 , BI 1021958 .</brief_summary>
	<brief_title>Effect Repeated Doses BI 1060469 BI 1021958 Glomerular Filtration Rate ( GFR ) Healthy Volunteers</brief_title>
	<detailed_description />
	<mesh_term>Naproxen</mesh_term>
	<mesh_term>Cimetidine</mesh_term>
	<criteria>Inclusion criterion : Healthy male subject accord investigator assessment , base follow criterion : complete medical history include physical examination , vital sign ( blood pressure ( BP ) , pulse rate ( PR ) ) , 12lead electrocardiogram ( ECG ) , clinical laboratory test , include negative test result occult blood stool ( subject assign Naproxen ) Age 18 45 year ( incl . ) Body Mass Index ( BMI ) 18.5 29.9 kg/m2 ( incl . ) Signed date write informed consent prior admission study accordance good clinical practice ( GCP ) local legislation Exclusion criterion : Any find medical examination ( include BP , PR ECG ) deviate normal judge clinically relevant investigator Repeated measurement systolic blood pressure great 140 mm Hg , diastolic blood pressure great 90 mm Hg , pulse rate outside range 50 90 mmHg Any laboratory value outside reference range investigator considers clinical relevance Serum creatinine laboratory value normal range GFR ( Glomerular Filtration Rate ) &lt; 90 mL/ min screen Urinary toral protein/creatinine ratio &gt; 0,1 mg protein/ mg creatinine Current history relevant kidney , urinary tract disease abnormality ( i.e . nephrolithiasis , hydronephrosis , acute chronic nephritis , renal injury , renal failure , infection ) Further exclusion criterion may apply</criteria>
	<gender>Male</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>40 Years</maximum_age>
	<verification_date>December 2014</verification_date>
</DOC>